检索

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

编号 16 (2012)

Monogennye formy sakharnogo diabeta

Zubkova N., Tikhonovich Y., Tyul'pakov A.

(Rus)

编号 5 (2017)

CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Chemikova N.

(Rus)

Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus

Demidov N.

(Rus)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

编号 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

编号 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

编号 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

编号 16 (2010)

SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Mkrtumyan A., Mkrtumyan A.

卷 28, 编号 12 (2021)

Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Novikova M., Demidov N.

(Rus)

卷 27, 编号 4 (2020)

Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?

Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.

(Rus)

编号 5 (2013)

SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA

Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.

(Rus)

编号 17 (2009)

ROSIGLITAZON: BEZOPASNOST', EFFEKTIVNOST' I VLIYaNIE NA KARDIOVASKULYaRNYE ISKhODY U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2

Petunina N., Antsiferov M.

编号 3 (2009)

Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus

Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.

卷 31, 编号 8 (2024)

Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone

Elsukova O., Nikitina E.

(Rus)

卷 28, 编号 12 (2021)

Insulin resistance - a common enemy for endocrinologists and cardiologists

Verbovoy A., Dolgikh Y.

(Rus)

The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus

Shevkunova N., Vorobyov M., Gushchin V.

(Rus)

卷 27, 编号 12 (2020)

Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»

Antsiferov M., Galstyan G.

(Rus)

Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice

Markova T.

(Rus)

The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)

Antsiferov M., Kvasnikov B.

(Rus)

编号 11 (2018)

Initiation of insulin therapy in patients with type 2 diabetes mellitus according to the Federal Diabetes Register in Moscow

Demidov N., Mishra O., Safronov T., Antsiferov M.

(Rus)

编号 4 (2018)

NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.

(Rus)

编号 16 (2017)

The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice

Antsiferov M.

(Rus)

编号 16 (2016)

Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients

Kovrigina E., Tyulganova V.

(Rus)

编号 5 (2016)

POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS

Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.

(Rus)

编号 2 (2016)

ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS

Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.

(Rus)

编号 5 (2015)

Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN

Chernikova N., Ivanova L., Abaeva F.

(Rus)

编号 16 (2014)

Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki

Surkova E.

(Rus)

编号 5 (2014)

METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA

Petunina N., Kuzina I.

(Rus)

编号 16 (2013)

Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa

Statsenko M., Derevyanchenko M.

(Rus)

编号 10 (2013)

Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa

Demidova I., Boeva V.

(Rus)

编号 5 (2013)

INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY

Antsiferov M., Schemthaner G., Ametov A.

(Rus)

编号 16 (2012)

Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa

Antsiferov M., Dorofeeva L.

(Rus)

编号 16 (2012)

Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike

Ametov A., Brashchenkova A.

(Rus)

编号 9 (2012)

METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA

Verbovoy A., Vorozhtsova E., Orlova T.

(Rus)

编号 3 (2012)

HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?

Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.

编号 16 (2011)

SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.

编号 16 (2010)

PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES

Rudakova A., Rudakova A.

编号 8 (2010)

ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS

Morkovskikh N., Morkovskikh N.

编号 17 (2009)

SOVREMENNYY VZGLYaD NA INSULINOTERAPIYu U BOL'NYKh SAKhARNYM DIABETOM

Ametov A., Karpova E.

编号 17 (2009)

MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY

Demidova I., Gorokhova T.

编号 3 (2009)

Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus

Petryaykina E., Dukhareva O., Rybkina I., Pronina E., Mikhaylova T., Garyaeva I., Mandzhieva E., Petryaikina E., Duchareva O., Ryibkina I., Pronina E., Michailova T., Garyaeva I., Mandjieva E.

卷 31, 编号 8 (2024)

Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)

Antsiferov M., Koteshkova O., Antsiferova D., Romashkina L., Golubeva Y.

(Rus)

卷 32, 编号 2 (2025)

Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children

Varlamova T., Vezikova N.

(Rus)

卷 31, 编号 2 (2024)

Screening, diagnosis and treatment of early carbohydrate metabolism disorders

Demidova I., Boeva V.

(Rus)

Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection

Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.

(Rus)

Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs

How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary

Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.

(Rus)

卷 30, 编号 3 (2023)

Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series

Smirnova E.

(Rus)

卷 27, 编号 12 (2020)

Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes

Shchukina E., Gromenkov V., Suprun Y., Mykhailichenko E., Beryozova E., Bagriy V., Golodnikov I.

(Rus)

卷 27, 编号 4 (2020)

Mkrtumyan A., Markova T.

(Rus)

卷 27, 编号 4 (2020)

The many faces of vitamin D

Verbovoy A., Dolgikh Y., Verbovaya N.

(Rus)

Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?

Biryukova E., Solovyova I.

(Rus)

编号 11 (2018)

Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus

Sorokina Y., Zanozin A., Zanozina O., Runov G.

(Rus)

编号 4 (2018)

NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Demidova T.

(Rus)

编号 16 (2017)

Diabetic distal polyneuropathy: the principles of diagnostics and therapy

Komelyagina E., Antsiferov M.

(Rus)

编号 5 (2017)

ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN

Petunina N., Terekhova A.

(Rus)

编号 5 (2016)

EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)

Koteshkova O., Molina L.

(Rus)

编号 13 (2015)

Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'

Pashentseva A., Verbovoy A.

(Rus)

编号 5 (2015)

Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa

Mkrtumyan A.

(Rus)

编号 16 (2014)

Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?

Glinkina I.

(Rus)

编号 5 (2014)

ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA

Yuryatin A.

(Rus)

编号 16 (2013)

Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa

Antsiferov M.

(Rus)

编号 16 (2012)

Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?

Antsiferov M., Galstyan G.

(Rus)

编号 3 (2012)

SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

编号 3 (2011)

COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Trukhina L., Petunina N., Truhina L.

编号 16 (2010)

ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR

Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.

编号 3 (2010)

Advance - movement forward

Petunina N., Petunina N.

编号 17 (2009)

OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI

Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.

编号 15 (2009)

Insulin resistance and heart diseases: is there a relationship?

Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.

编号 3 (2009)

Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL

Antsiferov M., Petraneva E., Anciferov M., Petraneva E.

卷 32, 编号 2 (2025)

The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children

Sadykova D., Shaydullina M., Aksenova A., Galimova L.

(Rus)

卷 31, 编号 2 (2024)

The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow

Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.

(Rus)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution

Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.

(Rus)

卷 29, 编号 11/12 (2022)

Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.

(Rus)

卷 28, 编号 12 (2021)

Obesity: an invisible disease

Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.

(Rus)

卷 26, 编号 14 (2019)

Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance

Ametov A., Tertychnaya E.

(Rus)